IFAM
KURA icon

Institutional & Family Asset Management’s Kura Oncology KURA Stock Holding History

Institutional & Family Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16
Closed -$196 – 777
2023
Q1 		$196 Hold
16
– – ﹤0.01% 714
2022
Q4 		$199 Hold
16
– – ﹤0.01% 699
2022
Q3 		$0 Hold
16
– – ﹤0.01% 740
2022
Q2 		$0 Hold
16
– – ﹤0.01% 759
2022
Q1 		$0 Buy
16
+14
+700% +$202 ﹤0.01% 808
2021
Q4 		$0 Sell
2
-15
-88% -$243 ﹤0.01% 863
2021
Q3 		$0 Sell
17
-11
-39% -$207 ﹤0.01% 945
2021
Q2 		$1K Hold
28
– – ﹤0.01% 896
2021
Q1 		$1K Sell
28
-17
-38% -$538 ﹤0.01% 873
2020
Q4 		$1K Sell
45
-2
-4% -$70 ﹤0.01% 840
2020
Q3 		$1K Hold
47
– – ﹤0.01% 794
2020
Q2 		$1K Sell
47
-14
-23% -$202 ﹤0.01% 783
2020
Q1 		$1K Hold
61
– – ﹤0.01% 747
2019
Q4 		$1K Hold
61
– – ﹤0.01% 816
2019
Q3 		$1K Sell
61
-1
-2% -$18 ﹤0.01% 789
2019
Q2 		$1K Hold
62
– – ﹤0.01% 806
2019
Q1 		$1K Hold
62
– – ﹤0.01% 796
2018
Q4 		$1K Hold
62
– – ﹤0.01% 774
2018
Q3 		$1K Buy
+62
New +$1.19K ﹤0.01% 808

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Institutional & Family Asset Management's KURA Position: Q2 2023 in Review

Institutional & Family Asset Management sold out of Kura Oncology (KURA) in Q2 2023, closing a stake of 16 shares — an estimated $196 sold.

Institutional & Family Asset Management first reported a position in KURA in Q3 2018 and held it in 19 quarters. The position peaked at $1K in Q2 2021. 148 funds tracked by Wall St. Rank hold KURA as of Q2 2023.

  • Institutional & Family Asset Management reported no remaining Kura Oncology position as of Q2 2023 after selling out during the quarter.
  • Institutional & Family Asset Management sold 16 Kura Oncology shares in Q2 2023, an estimated $196.
  • Institutional & Family Asset Management first reported a position in Kura Oncology in Q3 2018 and held it in 19 quarters.
  • Institutional & Family Asset Management's Kura Oncology position peaked at $1K in Q2 2021.
  • 148 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2023.

Based on Institutional & Family Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.